Pulsed Lavage in Implant-Based Breast Reconstruction
Launched by UNIVERSITY OF ALABAMA AT BIRMINGHAM · Oct 14, 2022
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying a technique called pulsed lavage, which is a way to wash out the area where breast implants are placed during reconstruction surgery after a mastectomy. The goal is to see if this method helps reduce complications after surgery, such as infections, fluid buildup, or problems with the implants. The trial is currently looking for female participants aged 18 to 75 who are planning to have immediate implant-based breast reconstruction.
If you or someone you know is considering this type of surgery and meets the age and gender requirements, you may be eligible to participate. Participants will need to sign a consent form to join the study and will be monitored for any issues after surgery. This trial is important because it could help improve recovery and outcomes for women undergoing breast reconstruction.
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • Female
- • Between 18 and 75 years of age, inclusive
- • Undergoing implant-based breast reconstruction (unilateral or bilateral) with immediate expander at mastectomy
- • Able to understand and willing to sign an Institutional Review Board (IRB) approved written informed consent document
- Exclusion Criteria:
- • Male
- • \< 18 years of age or \> 75 years of age
- • Undergoing implant-based breast reconstruction (unilateral or bilateral) with delayed expander at mastectomy
About University Of Alabama At Birmingham
The University of Alabama at Birmingham (UAB) is a prominent academic institution and research hub dedicated to advancing healthcare through innovative clinical trials. Renowned for its commitment to medical discovery and education, UAB conducts cutting-edge research across a wide array of disciplines, including oncology, cardiology, neurology, and public health. With a robust infrastructure for clinical research, UAB fosters collaboration among interdisciplinary teams, leveraging state-of-the-art facilities and resources to enhance the translation of scientific findings into effective treatments and interventions. As a leader in clinical research, UAB aims to improve patient outcomes and contribute to the broader medical community through rigorous trial design and implementation.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Birmingham, Alabama, United States
Birmingham, Alabama, United States
Patients applied
Trial Officials
Richard J Fix, MD
Principal Investigator
University of Alabama at Birmingham
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials